Hold on!

Warning: this link might be unsafe, please double check the link before you proceed.

https://www.reuters.com/business/healthcare-pharmaceuticals/us-patent-office-wont-review-two-novo-nordisk-patents-wegovy-ozempic-2023-10-02/